BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Seville LL, Shah N, Westwell AD, Chan WC. Modulation of pRB/E2F functions in the regulation of cell cycle and in cancer. Curr Cancer Drug Targets. 2005;5:159-170. [PMID: 15892617 DOI: 10.2174/1568009053765816] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Kühn JP, Schmid W, Körner S, Bochen F, Wemmert S, Rimbach H, Smola S, Radosa JC, Wagner M, Morris LGT, Bozzato V, Bozzato A, Schick B, Linxweiler M. HPV Status as Prognostic Biomarker in Head and Neck Cancer-Which Method Fits the Best for Outcome Prediction? Cancers (Basel) 2021;13:4730. [PMID: 34572957 DOI: 10.3390/cancers13184730] [Reference Citation Analysis]
2 Arizmendi-Izazaga A, Navarro-Tito N, Jiménez-Wences H, Mendoza-Catalán MA, Martínez-Carrillo DN, Zacapala-Gómez AE, Olea-Flores M, Dircio-Maldonado R, Torres-Rojas FI, Soto-Flores DG, Illades-Aguiar B, Ortiz-Ortiz J. Metabolic Reprogramming in Cancer: Role of HPV 16 Variants. Pathogens 2021;10:347. [PMID: 33809480 DOI: 10.3390/pathogens10030347] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mansoori B, Mohammadi A, Ditzel HJ, Duijf PHG, Khaze V, Gjerstorff MF, Baradaran B. HMGA2 as a Critical Regulator in Cancer Development. Genes (Basel) 2021;12:269. [PMID: 33668453 DOI: 10.3390/genes12020269] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
4 Wang X, Chang K, Gao J, Wei J, Xu G, Xiao L, Song G. MicroRNA-504 functions as a tumor suppressor in oral squamous cell carcinoma through inhibiting cell proliferation, migration and invasion by targeting CDK6. The International Journal of Biochemistry & Cell Biology 2020;119:105663. [DOI: 10.1016/j.biocel.2019.105663] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Frattaruolo L, Fiorillo M, Brindisi M, Curcio R, Dolce V, Lacret R, Truman AW, Sotgia F, Lisanti MP, Cappello AR. Thioalbamide, A Thioamidated Peptide from Amycolatopsis alba, Affects Tumor Growth and Stemness by Inducing Metabolic Dysfunction and Oxidative Stress. Cells 2019;8:E1408. [PMID: 31717378 DOI: 10.3390/cells8111408] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 7.3] [Reference Citation Analysis]
6 Li YJ, Du L, Aldana-Masangkay G, Wang X, Urak R, Forman SJ, Rosen ST, Chen Y. Regulation of miR-34b/c-targeted gene expression program by SUMOylation. Nucleic Acids Res 2018;46:7108-23. [PMID: 29893976 DOI: 10.1093/nar/gky484] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
7 Wang L, Shen H, Zhu D, Feng B, Yu L, Tian X, Ren C, Gao C, Li X, Ma D, Hu Z, Wang H. Increased high mobility group A 2 expression promotes transition of cervical intraepithelial neoplasm into cervical cancer. Oncotarget 2018;9:7891-901. [PMID: 29487700 DOI: 10.18632/oncotarget.24080] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
8 Park HY, Park SH, Jeong JW, Yoon D, Han MH, Lee DS, Choi G, Yim MJ, Lee JM, Kim DH, Kim GY, Choi IW, Kim S, Kim HS, Cha HJ, Choi YH. Induction of p53-Independent Apoptosis and G1 Cell Cycle Arrest by Fucoidan in HCT116 Human Colorectal Carcinoma Cells. Mar Drugs 2017;15:E154. [PMID: 28555064 DOI: 10.3390/md15060154] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
9 Shukla SK, Jha HC, El-Naccache DW, Robertson ES. An EBV recombinant deleted for residues 130-159 in EBNA3C can deregulate p53/Mdm2 and Cyclin D1/CDK6 which results in apoptosis and reduced cell proliferation. Oncotarget 2016;7:18116-34. [PMID: 26908453 DOI: 10.18632/oncotarget.7502] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
10 Yang H, Zheng W, Shuai X, Chang RM, Yu L, Fang F, Yang LY. MicroRNA-424 inhibits Akt3/E2F3 axis and tumor growth in hepatocellular carcinoma. Oncotarget 2015;6:27736-50. [PMID: 26315541 DOI: 10.18632/oncotarget.4811] [Cited by in Crossref: 33] [Cited by in F6Publishing: 42] [Article Influence: 5.5] [Reference Citation Analysis]
11 Qiu YQ, Yang CW, Lee YZ, Yang RB, Lee CH, Hsu HY, Chang CC, Lee SJ. Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget. Oncotarget 2015;6:2148-63. [PMID: 25669982 DOI: 10.18632/oncotarget.3236] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
12 Wu J, Sun S, Li W, Chen Y, Li H. pRb phosphorylation regulates the proliferation of supporting cells in gentamicin-damaged neonatal avian utricle. Neuroreport 2014;25:1144-50. [PMID: 25100553 DOI: 10.1097/WNR.0000000000000241] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
13 Xu Y, Zhang F, Qin L, Miao J, Sheng W, Xie Y, Xu X, Yang J, Qian H. Enhanced in-vitro and in-vivo suppression of A375 melanoma by combined IL-24/OSM adenoviral-mediated gene therapy. Melanoma Res 2014;24:20-31. [PMID: 24300090 DOI: 10.1097/CMR.0000000000000038] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
14 Li C, Wang J. Landscape and flux reveal a new global view and physical quantification of mammalian cell cycle. Proc Natl Acad Sci U S A 2014;111:14130-5. [PMID: 25228772 DOI: 10.1073/pnas.1408628111] [Cited by in Crossref: 67] [Cited by in F6Publishing: 50] [Article Influence: 8.4] [Reference Citation Analysis]
15 Federico A, Forzati F, Esposito F, Arra C, Palma G, Barbieri A, Palmieri D, Fedele M, Pierantoni GM, De Martino I, Fusco A. Hmga1/Hmga2 double knock-out mice display a "superpygmy" phenotype. Biol Open 2014;3:372-8. [PMID: 24728959 DOI: 10.1242/bio.20146759] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
16 Chen L, Chen J, Xu H. Sasanquasaponin from Camellia oleifera Abel. induces cell cycle arrest and apoptosis in human breast cancer MCF-7 cells. Fitoterapia 2013;84:123-9. [DOI: 10.1016/j.fitote.2012.11.009] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
17 Wierstra I. FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy. Adv Cancer Res 2013;119:191-419. [PMID: 23870513 DOI: 10.1016/B978-0-12-407190-2.00016-2] [Cited by in Crossref: 109] [Cited by in F6Publishing: 79] [Article Influence: 12.1] [Reference Citation Analysis]
18 Wei M, Liu B, Gu Q, Su L, Yu Y, Zhu Z. Stat6 cooperates with Sp1 in controlling breast cancer cell proliferation by modulating the expression of p21(Cip1/WAF1) and p27 (Kip1). Cell Oncol (Dordr) 2013;36:79-93. [PMID: 23184467 DOI: 10.1007/s13402-012-0115-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
19 Saha A, Lu J, Morizur L, Upadhyay SK, Aj MP, Robertson ES. E2F1 mediated apoptosis induced by the DNA damage response is blocked by EBV nuclear antigen 3C in lymphoblastoid cells. PLoS Pathog 2012;8:e1002573. [PMID: 22438805 DOI: 10.1371/journal.ppat.1002573] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
20 Sun Y, Fujigaki Y, Sakakima M, Fujikura T, Togawa A, Huang Y, Hishida A. Acquired resistance to rechallenge injury in rats that recovered from mild renal damage induced by uranyl acetate: accelerated proliferation and hepatocyte growth factor/c-Met axis. Clin Exp Nephrol 2011;15:666-75. [DOI: 10.1007/s10157-011-0453-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
21 Rieder CL. Mitosis in vertebrates: the G2/M and M/A transitions and their associated checkpoints. Chromosome Res 2011;19:291-306. [PMID: 21194009 DOI: 10.1007/s10577-010-9178-z] [Cited by in Crossref: 73] [Cited by in F6Publishing: 63] [Article Influence: 6.6] [Reference Citation Analysis]
22 Tyson JJ, Baumann WT, Chen C, Verdugo A, Tavassoly I, Wang Y, Weiner LM, Clarke R. Dynamic modelling of oestrogen signalling and cell fate in breast cancer cells. Nat Rev Cancer 2011;11:523-32. [PMID: 21677677 DOI: 10.1038/nrc3081] [Cited by in Crossref: 139] [Cited by in F6Publishing: 119] [Article Influence: 12.6] [Reference Citation Analysis]
23 Gatouillat G, Balasse E, Joseph-Pietras D, Morjani H, Madoulet C. Resveratrol induces cell-cycle disruption and apoptosis in chemoresistant B16 melanoma. J Cell Biochem 2010;110:893-902. [PMID: 20564188 DOI: 10.1002/jcb.22601] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 5.6] [Reference Citation Analysis]
24 O'Han MK, Baxter RC, Schedlich LJ. Effects of endogenous insulin-like growth factor binding protein-3 on cell cycle regulation in breast cancer cells. Growth Factors 2009;27:394-408. [PMID: 19919528 DOI: 10.3109/08977190903185032] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
25 Burhans WC, Heintz NH. The cell cycle is a redox cycle: linking phase-specific targets to cell fate. Free Radic Biol Med 2009;47:1282-93. [PMID: 19486941 DOI: 10.1016/j.freeradbiomed.2009.05.026] [Cited by in Crossref: 239] [Cited by in F6Publishing: 224] [Article Influence: 18.4] [Reference Citation Analysis]
26 Evangelisti C, Astolfi A, Gaboardi GC, Tazzari P, Pession A, Goto K, Martelli AM. TIS21/BTG2/PC3 and cyclin D1 are key determinants of nuclear diacylglycerol kinase-ζ-dependent cell cycle arrest. Cellular Signalling 2009;21:801-9. [DOI: 10.1016/j.cellsig.2009.01.027] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
27 Wang F, Ezell SJ, Zhang Y, Wang W, Rayburn ER, Nadkarni DH, Murugesan S, Velu SE, Zhang R. FBA-TPQ, a novel marine-derived compound as experimental therapy for prostate cancer. Invest New Drugs 2010;28:234-41. [PMID: 19274441 DOI: 10.1007/s10637-009-9232-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
28 Orzáez M, Gortat A, Mondragón L, Bachs O, Pérez-Payá E. ATP-noncompetitive inhibitors of CDK-cyclin complexes. ChemMedChem 2009;4:19-24. [PMID: 19039815 DOI: 10.1002/cmdc.200800185] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
29 Sahin O, Fröhlich H, Löbke C, Korf U, Burmester S, Majety M, Mattern J, Schupp I, Chaouiya C, Thieffry D, Poustka A, Wiemann S, Beissbarth T, Arlt D. Modeling ERBB receptor-regulated G1/S transition to find novel targets for de novo trastuzumab resistance. BMC Syst Biol 2009;3:1. [PMID: 19118495 DOI: 10.1186/1752-0509-3-1] [Cited by in Crossref: 160] [Cited by in F6Publishing: 104] [Article Influence: 12.3] [Reference Citation Analysis]
30 Park EY, Lee KW, Lee HW, Cho YW, Baek NI, Chung HG, Jeong TS, Choi MS, Lee KT. The ethanol extract from Artemisia princeps Pampanini induces p53-mediated G1 phase arrest in A172 human neuroblastoma cells. J Med Food 2008;11:237-45. [PMID: 18598164 DOI: 10.1089/jmf.2007.609] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
31 Wang W, Rayburn ER, Hao M, Zhao Y, Hill DL, Zhang R, Wang H. Experimental therapy of prostate cancer with novel natural product anti-cancer ginsenosides. Prostate 2008;68:809-19. [PMID: 18324646 DOI: 10.1002/pros.20742] [Cited by in Crossref: 78] [Cited by in F6Publishing: 74] [Article Influence: 5.6] [Reference Citation Analysis]
32 Li J, Ran C, Li E, Gordon F, Comstock G, Siddiqui H, Cleghorn W, Chen HZ, Kornacker K, Liu CG, Pandit SK, Khanizadeh M, Weinstein M, Leone G, de Bruin A. Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development. Dev Cell 2008;14:62-75. [PMID: 18194653 DOI: 10.1016/j.devcel.2007.10.017] [Cited by in Crossref: 135] [Cited by in F6Publishing: 134] [Article Influence: 9.6] [Reference Citation Analysis]
33 Bianchi F, Nuciforo P, Vecchi M, Bernard L, Tizzoni L, Marchetti A, Buttitta F, Felicioni L, Nicassio F, Di Fiore PP. Survival prediction of stage I lung adenocarcinomas by expression of 10 genes. J Clin Invest 2007;117:3436-44. [PMID: 17948124 DOI: 10.1172/JCI32007] [Cited by in Crossref: 86] [Cited by in F6Publishing: 47] [Article Influence: 6.1] [Reference Citation Analysis]
34 Los AP, de Widt J, van Blitterswijk WJ, Divecha N. Is there a role for diacylglycerol kinase-zeta in cell cycle regulation? Adv Enzyme Regul 2008;48:31-9. [PMID: 18358241 DOI: 10.1016/j.advenzreg.2008.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
35 Fusco A, Fedele M. Roles of HMGA proteins in cancer. Nat Rev Cancer 2007;7:899-910. [PMID: 18004397 DOI: 10.1038/nrc2271] [Cited by in Crossref: 486] [Cited by in F6Publishing: 475] [Article Influence: 34.7] [Reference Citation Analysis]
36 Turowska O, Nauman A, Pietrzak M, Popławski P, Master A, Nygard M, Bondesson M, Tanski Z, Puzianowska-kuznicka M. Overexpression of E2F1 in Clear Cell Renal Cell Carcinoma: A Potential Impact of Erroneous Regulation by Thyroid Hormone Nuclear Receptors. Thyroid 2007;17:1039-48. [DOI: 10.1089/thy.2007.0075] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
37 Lah JJ, Cui W, Hu KQ. Effects and mechanisms of silibinin on human hepatoma cell lines. World J Gastroenterol 2007; 13(40): 5299-5305 [PMID: 17879397 DOI: 10.3748/wjg.v13.i40.5299] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 60] [Article Influence: 4.3] [Reference Citation Analysis]
38 Goyeneche AA, Carón RW, Telleria CM. Mifepristone inhibits ovarian cancer cell growth in vitro and in vivo. Clin Cancer Res 2007;13:3370-9. [PMID: 17545545 DOI: 10.1158/1078-0432.CCR-07-0164] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 3.1] [Reference Citation Analysis]
39 Chignola R, Del Fabbro A, Pellegrina CD, Milotti E. Ab initio phenomenological simulation of the growth of large tumor cell populations. Phys Biol 2007;4:114-33. [PMID: 17664656 DOI: 10.1088/1478-3975/4/2/005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
40 Milotti E, Del Fabbro A, Dalla Pellegrina C, Chignola R. Dynamics of allosteric action in multisite protein modification. Physica A: Statistical Mechanics and its Applications 2007;379:133-50. [DOI: 10.1016/j.physa.2006.12.034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
41 Kraveka JM, Li L, Szulc ZM, Bielawski J, Ogretmen B, Hannun YA, Obeid LM, Bielawska A. Involvement of dihydroceramide desaturase in cell cycle progression in human neuroblastoma cells. J Biol Chem 2007;282:16718-28. [PMID: 17283068 DOI: 10.1074/jbc.M700647200] [Cited by in Crossref: 117] [Cited by in F6Publishing: 77] [Article Influence: 7.8] [Reference Citation Analysis]
42 Kim SY, Kim JY, Kim SH, Bae HJ, Yi H, Yoon SH, Koo BS, Kwon M, Cho JY, Lee CE, Hong S. Surfactin from Bacillus subtilis displays anti-proliferative effect via apoptosis induction, cell cycle arrest and survival signaling suppression. FEBS Lett 2007;581:865-71. [PMID: 17292358 DOI: 10.1016/j.febslet.2007.01.059] [Cited by in Crossref: 114] [Cited by in F6Publishing: 94] [Article Influence: 7.6] [Reference Citation Analysis]
43 Chignola R, Dalla Pellegrina C, Fabbro AD, Milotti E. Thresholds, long delays and stability from generalized allosteric effect in protein networks. Physica A: Statistical Mechanics and its Applications 2006;371:463-72. [DOI: 10.1016/j.physa.2006.03.044] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
44 Fedele M, Visone R, De Martino I, Troncone G, Palmieri D, Battista S, Ciarmiello A, Pallante P, Arra C, Melillo RM, Helin K, Croce CM, Fusco A. HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. Cancer Cell 2006;9:459-71. [PMID: 16766265 DOI: 10.1016/j.ccr.2006.04.024] [Cited by in Crossref: 166] [Cited by in F6Publishing: 160] [Article Influence: 10.4] [Reference Citation Analysis]
45 Gao N, Kramer L, Rahmani M, Dent P, Grant S. The Three-Substituted Indolinone Cyclin-Dependent Kinase 2 Inhibitor 3-[1-(3 H -Imidazol-4-yl)-meth-( Z )-ylidene]-5-methoxy-1,3-dihydro-indol-2-one (SU9516) Kills Human Leukemia Cells via Down-Regulation of Mcl-1 through a Transcriptional Mechanism. Mol Pharmacol 2006;70:645-55. [DOI: 10.1124/mol.106.024505] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
46 Camouse MM, Hanneman KK, Conrad EP, Baron ED. Protective effects of tea polyphenols and caffeine. Expert Rev Anticancer Ther 2005;5:1061-8. [PMID: 16336097 DOI: 10.1586/14737140.5.6.1061] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
47 Nemajerova A, Wolff S, Petrenko O, Moll UM. Viral and cellular oncogenes induce rapid mitochondrial translocation of p53 in primary epithelial and endothelial cells early in apoptosis. FEBS Lett 2005;579:6079-83. [PMID: 16226255 DOI: 10.1016/j.febslet.2005.09.074] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]